154 related articles for article (PubMed ID: 36400805)
1. Identification of key biomarkers for STAD using filter feature selection approaches.
Wang Y; Wang J; Hu Y; Shangguan J; Song Q; Xu J; Wang H; Xue M; Wang L; Zhang Y
Sci Rep; 2022 Nov; 12(1):19854. PubMed ID: 36400805
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
3. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets.
Ren N; Liang B; Li Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
5. Gastric Cancer Biomarker Candidates Identified by Machine Learning and Integrative Bioinformatics: Toward Personalized Medicine.
Sinnarasan VSP; Paul D; Das R; Venkatesan A
OMICS; 2023 Jun; 27(6):260-272. PubMed ID: 37229622
[TBL] [Abstract][Full Text] [Related]
6. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
7. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
8. Identification of aberrantly expressed long non-coding RNAs in stomach adenocarcinoma.
Gu J; Li Y; Fan L; Zhao Q; Tan B; Hua K; Wu G
Oncotarget; 2017 Jul; 8(30):49201-49216. PubMed ID: 28484081
[TBL] [Abstract][Full Text] [Related]
9. Screening lncRNAs with diagnostic and prognostic value for human stomach adenocarcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Li Q; Liu X; Gu J; Zhu J; Wei Z; Huang H
Mol Genet Genomic Med; 2020 Nov; 8(11):e1512. PubMed ID: 33002344
[TBL] [Abstract][Full Text] [Related]
10. WGCNA identification of TLR7 as a novel diagnostic biomarker, progression and prognostic indicator, and immunotherapeutic target for stomach adenocarcinoma.
Yuan Q; Zhou Q; Ren J; Wang G; Yin C; Shang D; Xia S
Cancer Med; 2021 Jun; 10(12):4004-4016. PubMed ID: 33982398
[TBL] [Abstract][Full Text] [Related]
11. Identification of a 14-lncRNA Signature and Construction of a Prognostic Nomogram Predicting Overall Survival of Gastric Cancer.
Nie K; Deng Z; Zheng Z; Wen Y; Pan J; Jiang X; Yan Y; Liu P; Liu F; Li P
DNA Cell Biol; 2020 Sep; 39(9):1532-1544. PubMed ID: 32644844
[TBL] [Abstract][Full Text] [Related]
12. Highly accurate two-gene signature for gastric cancer.
Yan Z; Xu W; Xiong Y; Cheng Y; Xu H; Wang Z; Zheng G
Med Oncol; 2013; 30(2):584. PubMed ID: 23606240
[TBL] [Abstract][Full Text] [Related]
13. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
14. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
Front Immunol; 2022; 13():854785. PubMed ID: 35392086
[TBL] [Abstract][Full Text] [Related]
15. GCGene: a gene resource for gastric cancer with literature evidence.
Zhao M; Chen L; Liu Y; Qu H
Oncotarget; 2016 Jun; 7(23):33983-93. PubMed ID: 27127885
[TBL] [Abstract][Full Text] [Related]
16. Could microtubule inhibitors be the best choice of therapy in gastric cancer with high immune activity: mutant DYNC1H1 as a biomarker.
Bai J; Yang B; Shi R; Shao X; Yang Y; Wang F; Xiao J; Qu X; Liu Y; Zhang Y; Li Z
Aging (Albany NY); 2020 Nov; 12(24):25101-25119. PubMed ID: 33221769
[TBL] [Abstract][Full Text] [Related]
17. Identification of biomarkers for diagnosis of gastric cancer by bioinformatics.
Wang DG; Chen G; Wen XY; Wang D; Cheng ZH; Sun SQ
Asian Pac J Cancer Prev; 2015; 16(4):1361-5. PubMed ID: 25743799
[TBL] [Abstract][Full Text] [Related]
18. A novel microRNA signature predicts survival in stomach adenocarcinoma.
Ding B; Gao X; Li H; Liu L; Hao X
Oncotarget; 2017 Apr; 8(17):28144-28153. PubMed ID: 28423653
[TBL] [Abstract][Full Text] [Related]
19. High plasma levels of COL10A1 are associated with advanced tumor stage in gastric cancer patients.
Necula L; Matei L; Dragu D; Pitica I; Neagu AI; Bleotu C; Dima S; Popescu I; Diaconu CC; Chivu-Economescu M
World J Gastroenterol; 2020 Jun; 26(22):3024-3033. PubMed ID: 32587446
[TBL] [Abstract][Full Text] [Related]
20. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
